Document is current
Any future updates will be listed below
-
Authors
Parker, Kyle E. https://orcid.org/0000-0002-5432-6079
Lee, Juhyun https://orcid.org/0000-0002-3913-3332
Kim, Jenny R. https://orcid.org/0000-0003-1393-7815
Kawakami, Chinatsu
Kim, Choong Yeon https://orcid.org/0000-0002-0674-7215
Qazi, Raza https://orcid.org/0000-0002-9491-5783
Jang, Kyung-In
Jeong, Jae-Woong https://orcid.org/0000-0001-7607-5453
McCall, Jordan G. https://orcid.org/0000-0001-8295-0664
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS117899)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA055047)
Brain and Behavior Research Foundation (28565)
National Research Foundation of Korea (2021R1A2C4001483)
National Research Foundation of Korea (2020M3A9G8018572)
KAIST (Global Singularity Research Program)
- License Information
-
More Information
Article History
Received: 28 September 2021
Accepted: 7 July 2022
First Online: 21 October 2022
Competing interests
: J.-W.J. and J.G.M. share two US patents (US 10,617,300 B2 and 11,160,489 B2) for injectable and implantable cellular-scale electronic devices, but do not earn income related to these patents. The other authors have no conflicts of interest.
